Scios/Medtronic
This article was originally published in The Gray Sheet
Executive Summary
Firms will begin a 20-patient pilot study this quarter at Karolinska Hospital in Sweden to evaluate hemodynamic and clinical effects of Scios' Natrecor investigational drug using information collected by Medtronic's Chronicle implantable hemodynamic monitor during and after infusions. Scios' amended new drug application was filed in January. Medtronic plans to file a PMA for the Chronicle by year-end
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.